338
Participants
Start Date
June 30, 2009
Primary Completion Date
March 31, 2012
Study Completion Date
June 30, 2013
dalteparin
Daily subcutaneous injection 200IU/kg dalteparin
Bringham and Women's Hospital, Boston
Vermont Cancer Center at Fletcher Allen Health Care, Burlington
University of CT Health Center, Farmington
Eastern Connecticut Hematology and Oncology Associates, Norwich
Stony Brook University, Medical Center, Stony Brook
University of Rochester Medical Center, Rochester
Pennsylvania Oncology Hematology Associates, Philadelphia
Georgetown University Hospital-Lombardi Cancer Ctr, Washington D.C.
University of Virginia, Charlottesville
Duke University Medical Center, Durham
Atlanta Institute for Medical Research, Decatur
Halifax Health, Daytona Beach
James Graham Brown Cancer Center, Louisville
Henry Ford Hospital K-15, Detroit
MidDakota Clinic, Bismarck
Orchard Healthcare Research Inc., Skokie
MD Anderson Cancer Center, Houston
University of Utah, Salt Lake City
Arizona Cancer Center, Tucson
Harbor-UCLA Medical Center, Torrance
Bay Area Cancer Research Group, Pleasant Hill
LKH Graz Univrsitatstklinik fur Innere Medizin, Graz
Medizinische Universitat Innsbruck Studienambulanz Hamatologie, Innsbruck
KH d. Elizabethinen Linz GmbH Servicestelle fur klin. Studien und Universitare Angelegenheiten, Linz
KH der Barmherzigen Schwestern, Linz
Dialysestation Landesklinkum St.Poelten, Sankt Pölten
Medizinische Universitat Wien, Vienna
University of Alberta, Edmonton
Vancouver General Hospital, Vancouver
Queen Elizabeth II Health Sciences Centre, Halifax
London Health Sciences Centre, London
Ottawa Health Research Institute, Ottawa
University Health Network-Toronto General Hospital, Toronto
Maisonneuve-Rosemont Hospital, Montreal
Sir Mortimer B. Davis Jewish General Hospital, Montreal
Gelre Ziekenhuizen-Locatie Apeldoorn, Apeldoorn
Orbis Medisch Centrum, Sittard-Geleen, Sittard-Geleen
Hospital clinic i Provincial de Agencia de Ensayos Clinicos, Barcelona
Hospital General Santa Maria del Rosell, Caragena (Murcia)
Hospital Virgen de la Arrixaca, El Palmar (Murcia)
Hospital Universitari Dr Josep Trueta, Girona
Clinica Universitaria de Navarra, Pamplona
Lead Sponsor
Pfizer
INDUSTRY